LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | PLX-4720 | 1.11 | uM | LJP5 | 3 | K03 | 72 | hr | 868 | 3229 | 3486 | 0.9262 | 0.9017 |
| MDA-MB-231 | QL-X-138 | 1.11 | uM | LJP6 | 1 | F21 | 72 | hr | 868 | 2529 | 3486 | 0.7254 | 0.6343 |
| MDA-MB-231 | QL-X-138 | 1.11 | uM | LJP6 | 2 | F21 | 72 | hr | 868 | 2545 | 3486 | 0.7300 | 0.6405 |
| MDA-MB-231 | QL-X-138 | 1.11 | uM | LJP6 | 3 | F21 | 72 | hr | 868 | 2377 | 3486 | 0.6818 | 0.5763 |
| MDA-MB-231 | QL-XII-47 | 1.11 | uM | LJP6 | 1 | O21 | 72 | hr | 868 | 999 | 3486 | 0.2865 | 0.0500 |
| MDA-MB-231 | QL-XII-47 | 1.11 | uM | LJP6 | 2 | O21 | 72 | hr | 868 | 1085 | 3486 | 0.3112 | 0.0828 |
| MDA-MB-231 | QL-XII-47 | 1.11 | uM | LJP6 | 3 | O21 | 72 | hr | 868 | 970 | 3486 | 0.2782 | 0.0389 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 1 | K09 | 72 | hr | 868 | 1094 | 3486 | 0.3138 | 0.0863 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 2 | K09 | 72 | hr | 868 | 1238 | 3486 | 0.3551 | 0.1413 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 3 | K09 | 72 | hr | 868 | 1106 | 3486 | 0.3172 | 0.0909 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 1 | K09 | 72 | hr | 868 | 1214 | 3486 | 0.3482 | 0.1321 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 2 | K09 | 72 | hr | 868 | 1303 | 3486 | 0.3737 | 0.1661 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 3 | K09 | 72 | hr | 868 | 1315 | 3486 | 0.3772 | 0.1707 |
| MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 1 | J03 | 72 | hr | 868 | 2973 | 3486 | 0.8527 | 0.8039 |
| MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 2 | J03 | 72 | hr | 868 | 2878 | 3486 | 0.8255 | 0.7676 |
| MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 3 | J03 | 72 | hr | 868 | 2927 | 3486 | 0.8396 | 0.7864 |
| MDA-MB-231 | Ruxolitinib | 1.11 | uM | LJP5 | 1 | O15 | 72 | hr | 868 | 3068 | 3486 | 0.8800 | 0.8402 |
| MDA-MB-231 | Ruxolitinib | 1.11 | uM | LJP5 | 2 | O15 | 72 | hr | 868 | 3650 | 3486 | 1.0469 | 1.0625 |
| MDA-MB-231 | Ruxolitinib | 1.11 | uM | LJP5 | 3 | O15 | 72 | hr | 868 | 3260 | 3486 | 0.9351 | 0.9135 |
| MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 1 | G09 | 72 | hr | 868 | 3887 | 3486 | 1.1149 | 1.1530 |
| MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 2 | G09 | 72 | hr | 868 | 3837 | 3486 | 1.1006 | 1.1339 |
| MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 3 | G09 | 72 | hr | 868 | 3692 | 3486 | 1.0590 | 1.0785 |
| MDA-MB-231 | Saracatinib | 1.11 | uM | LJP6 | 1 | D09 | 72 | hr | 868 | 2217 | 3486 | 0.6359 | 0.5152 |
| MDA-MB-231 | Saracatinib | 1.11 | uM | LJP6 | 2 | D09 | 72 | hr | 868 | 1995 | 3486 | 0.5722 | 0.4304 |
| MDA-MB-231 | Saracatinib | 1.11 | uM | LJP6 | 3 | D09 | 72 | hr | 868 | 2131 | 3486 | 0.6112 | 0.4823 |